All lobbying filings

W STRATEGIES, LLC

W STRATEGIES, LLC filed a Q4 termination report for ELEVATEBIO on April 16, 2026, reporting $30,000 in lobbying income.

Lobbying for ELEVATEBIO · Cell and gene therapy.

All filings by W STRATEGIES, LLC · Everything ELEVATEBIO has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Apr 16, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 1

DARREN WILLCOX

Previously held: Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Health Issues

Education about innovation in cell and gene therapies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.